News

In the media

Johnson & Johnson Opens JLABS @ NYC

By Global Cosmetic Industry

Read full story
Other news

Riding the Start-Up Roller Coaster: What It's Really Like to Be a Healthcare Entrepreneur

By Leena Rao

Read full story
Other news

IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.

By Ideaya Biosciences

Read full story
Other news

Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets

By JLABS

Read full story
Other news

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

By JLABS

Read full story
Other news

Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis

By JLABS

Read full story
Other news

Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

By JLABS

Read full story
Other news

Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates

By JLABS

Read full story
Other news

JLABS TMC Company finds Growth in Shrinking Cells

By JLABS

Read full story
Other news

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

By JLABS

Read full story
Other news

Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline

By JLABS

Read full story
Other news

Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease

By JLABS

Read full story
Other news

Ensysce Biosciences has received Fast Track designation from the FDA for the development of abuse-resistant opioid drug PF614

By JLABS

Read full story
Other news

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm for Drug Development

By JLABS

Read full story
Other news

Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder

By JLABS

Read full story